Status:
TERMINATED
Effect of Modified Mirror Therapy in Patients With Upper Limb Hemiparesis After Stroke
Lead Sponsor:
Zeng Changhao
Conditions:
Stroke
Eligibility:
All Genders
35-70 years
Phase:
NA
Brief Summary
This was a randomized controlled study in China conducted during Aug. 2022 to Aug. 2023. Totally, patients with upper limb hemiplegia after stroke, who were admitted in the Department of Rehabilitatio...
Detailed Description
Upper limb hemiparesis is a motor and sensory disorder that occurs after stroke, with an incidence rate of up to 55% to 75%. Effective upper limb rehabilitation methods help reduce the occurrence of d...
Eligibility Criteria
Inclusion
- Meeting the diagnostic criteria of stroke, by CT or MRI.
- The first-onset stroke.
- Presenting with unilateral upper limb dysfunction, within Brunnstrom stage Ⅱ to Ⅳ on the affected side, and Ash-worth score ≤2.
- No obvious cognitive impairment, with Mini-Mental State Examination (MMSE) score \>21 points.
- National Institutes of Health Stroke Scale (NIHSS) score \>4 points.
- Stable vital signs, no severe diseases such as cancer, liver or kidney disorders.
- Aged 35-70 years.
- Courses of diseases 2-6 weeks.
Exclusion
- Presence of aphasia, apraxia, or hemispatial neglect.
- Presence of hearing, vision, or comprehension impairments that hinder diagnosis and treatment.
- Complicate with traumas, fractures, or other progressive neuro-muscular system diseases.
- Severe spasticity in the upper limbs.
- Severe bone, joint, or muscle deformities or lesions.
- History of mental illness.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT06199375
Start Date
August 1 2022
End Date
August 31 2023
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zheng da yi fu yuan hospital
Zhengzhou, Henan, China, 450000